Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease
Top Cited Papers
- 25 April 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 165 (8), 923-928
- https://doi.org/10.1001/archinte.165.8.923
Abstract
Research from JAMA Internal Medicine — Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney DiseaseKeywords
This publication has 27 references indexed in Scilit:
- Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999Nephrology Dialysis Transplantation, 2003
- End-stage renal disease in sub-Saharan and South AfricaKidney International, 2003
- Does non-malignant hypertension cause renal insufficiency? Evidence-based perspectiveCurrent Opinion in Nephrology and Hypertension, 2002
- Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000)Kidney International, 2002
- Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trialsJournal of Human Hypertension, 2001
- Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosisNephrology Dialysis Transplantation, 2000
- Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative studyAmerican Journal of Kidney Diseases, 2000
- The link between hypertension and nephrosclerosisAmerican Journal of Kidney Diseases, 1995
- Clinical Documentation of End-Stage Renal Disease Due to HypertensionAmerican Journal of Kidney Diseases, 1994
- Renal pathology in hypertension and the effects of treatment.British Journal of Clinical Pharmacology, 1982